Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Cost-utility of Somatocognitive Therapy Versus Treatment as Usual for Provoked (Localized) Vestibulodynia - a Randomized Clinical Trial (ProLoVe Study)

NCT04613713 is registered in ClinicalTrials.gov with Oslo Metropolitan University as lead sponsor.

NCT NCT04613713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04613713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Cost-utility of Somatocognitive Therapy Versus Treatment as Usual for Provoked (Localized) Vestibulodynia - a Randomized Clinical Trial (ProLoVe Study)
Lead sponsor
Oslo Metropolitan University
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2021
Completion date
December 31, 2025
Enrollment
128 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vestibulodynia, vulvodynia